Boehringer Ingelheim Extends Use of Medidata Rave

Article

Medidata and Boehringer Ingelheim announced a five-year renewal of their collaboration in the area of electronic data capture. The new agreement extends the use of Rave EDC for Boehringer Ingelheim's clinical trials worldwide and includes myMedidata.

Read more about the collaboration here.


Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.